DJIA 17,856.78 -278.94 -1.54%
NASDAQ 4,927.37 -55.44 -1.11%
S&P 500 2,071.26 -29.78 -1.42%
market minute promo

GlaxoSmithKline (NYSE: GSK)



company name or ticker
Company Photos
(Click to zoom)

State of the Union Address Investing Idea: Precision Medicine

There are plenty of companies developing precision medicine drugs already, and investors would be wise to watch key players.

CAR-T Vs ErbB3 Market Opportunity Comparison

Johnson & Johnson Riding High On Ebola Vaccines

3 Warning Signs You've Invested in a Dangerous Biotech Stock

Three Motley Fool analysts help investors spot biotech stock warning signals.

OncoMed Starts Expansion Stage Study for Solid Tumor Drug - Analyst Blog

Building A Monthly Income Portfolio

Isis Pharmaceuticals Earns Milestone Payment from Biogen - Analyst Blog

Vical Up on Deal with AnGes to Develop Ebola Treatment - Analyst Blog

3 Slides That Tell You Everything You Need to Know About GlaxoSmithKline PLC

With the "Super Bowl" of all healthcare conferences under way in San Francisco, these three slides perfectly sum up what investors need to know about GlaxoSmithKline.

Best 3 Yielding Buy-Rated Stocks: BCE, GSK, APU